Genus (LSE:GNS)

Genus applies science to animal breeding. Its non-genetically modified organism technology is applicable across all livestock species but is only commercialised by Genus in the bovine and porcine farming sectors. It is a provider of bovine genetics and reproduction services, marketing in more than 70 countries.

Related Articles

• Friday, 18th December, 2020 | Kirsteen Mackay

  2 soaring small-cap growth stocks of 2020. Will their share prices fly in 2021?

  Many biotech and food companies fared well this year. Will these FTSE AIM All Share (INDEXFTSE: AXX) small-cap growth stocks continue to prove their... Read More »

• Tuesday, 8th September, 2020 | Jabran Khan

  £1,000 to invest? I think buying this FTSE stock will make you money!

  Jabran Khan picks this FTSE 250 share as a great opportunity for you, especially on the back of impressive full-year results. Read More »

• Thursday, 2nd April, 2020 | Tezcan Gecgil, PhD

  2 FTSE shares I’d buy in an ISA in April

  Here are two FTSE shares I think may be appropriate for a Stocks and Shares ISA when the annual allowance resets in a few... Read More »

• Friday, 6th March, 2020 | Harvey Jones

  These 2 FTSE 250 stocks are rising despite the crash. Here’s what I’d do now

  These two FTSE 250 growth stocks are climbing while markets plunge. Read More »

• Wednesday, 4th December, 2019 | Rupert Hargreaves

  Forget Bitcoin! I’d buy these undervalued FTSE 250 growth stocks today

  After recent falls, these FTSE 250 growth stocks look too cheap to pass up says this Fool. Read More »

• Thursday, 5th September, 2019 | Alan Oscroft

  Why I think this FTSE 250 stock could trash the GSK share price

  I love GlaxoSmithKline plc (LON: GSK). But I reckon this FTSE 250 (INDEXFTSE: MCX) stock could beat it in the growth stakes. Read More »

• Thursday, 6th September, 2018 | Peter Stephens

  Is the GSK share price primed to beat the FTSE 100?

  Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)? Read More »

• Wednesday, 28th February, 2018 | Roland Head

  2 stunning growth stocks you might regret not buying

  Roland Head breaks down the latest numbers from two mid-cap growth stocks. Read More »

• Thursday, 7th September, 2017 | Peter Stephens

  Two growth stocks that could make you a millionaire

  These two shares offer a potent mix of growth and value potential. Read More »

• Thursday, 23rd February, 2017 | Kevin Godbold

  Why I’d buy Tristel plc and avoid Genus plc after HY results

  Half-year results reveal two different stories with Tristel plc (LON: TSTL) and Genus plc (LON: GNS) Read More »